• header2

    Cancer Care that is
    Patient Focused

    “Clinical staff reported that the MES equipment is modern, enables greater accuracy of diagnosis, screening or treatment, leads to a consistently higher quality of care, enhances the clinical services and has a positive impact on patient throughput and reducing waiting times."
    - Excerpt from a recent Benefits Realisation at the St. James’s Institute of Oncology, Leeds, England


    See our Projects

Managed Equipment Service

mes icon2HTI's team of experts work closely with its NHS partners to develop long-range strategic plans for all their medical equipment needs; and then we procure, install, manage, maintain, and lifecyle. 

Healthcare Services

healthcare services icon2 The directors of HTI have over 30 years of experience in healthcare delivery and have developed more than 200 diagnostic and treatment centres in the USA, Europe and Latin America.

Center Development

proton devel iconHTI's model targets partnership opportunities and encourages strategic alliances between the public and private sectors; offering business planning, financing options, design, project construction and on-going management.


Why Proton Therapy?

Proton Video LinkProton therapy has clinically proven to provide positive results for cancer patients with certain site specific types of cancer.  Our mission is to expand patient and consultant access to technologies and services which will improve clinical outcome for patients.

Our experience

HS icon The directors of HTI have over 30 years of experience in healthcare delivery and have developed more than 200 diagnostic and treatment centres in the USA, Europe and Latin America. Click here to see a full list of our previous projects.  

HTI escorts Jonathan Dimbleby at new Queens Mary's Hospital in Sidcup
HTI escorts Jonathan Dimbleby at new Queens Mary's Hospital in Sidcup

Cancer care specialists unveil plans for growth after Leeds deal
HTI are contracted to provide a turnkey design, build and equip satellite cancer centre to the main Guy's St.Thomas centre in London located in Sidcup on the Queen Mary campus. The agreement is funded directly through GSTT [ ... ]

New Compact Gantry from IBA Cleared by FDA
New Compact Gantry from IBA Cleared by FDA

New Compact Gantry for ProteusONE Proton Therapy System FDA Cleared
In a press release on July 16th of 2014, IBA announced that it has received Marketing Authorization from the U.S. Food and Drug A dministration (FDA) for its Compact Gantry Beam Line
IBA explains that, "Proteus® ONE [ ... ]